Dr. Matthew L. Wilner, MD

Dr. Wilner practices at Texas Health Plano in Plano, Texas, part of Texas Health Resources.

Dr. Wilner's NPI, 1245284785, was assigned on May 20, 2006. Dr. Wilner graduated from New York University School of Medicine in 1984. Dr. Wilner's Texas license number on file is H8893.

Dr. Wilner's primary practice is Texas Health Plano, at 6200 W Parker Rd, Plano, TX 75093 in Collin County. The practice phone is (972) 981-8000.

Dr. Wilner's primary practice is Texas Health Plano in Plano, Texas, part of Texas Health Resources. Dr. Wilner is also affiliated with Texas Health Dallas. The medical group on file is Urology Clinics of North Texas. Dmand AI also links Dr. Wilner to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilner practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Wilner's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Wilner is board certified in urology by the American Board of Urology. Dmand AI has Dr. Wilner's licenses on file in 3 states: Texas, California and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Wilner treats.

CMS data shows 25,273 Medicare services from Dr. Wilner across 46 procedure codes in 2024, for 1,238 Medicare patients. Medicare paid $427,696 for them.

CMS counts 1,238 Medicare patients who saw Dr. Wilner in 2024. The largest group is 75 to 84, with 521 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilner's median patient age at 72, with 17% women.

In 2024, Dr. Wilner wrote 4,078 Medicare Part D claims for 958 patients. 85% of them were for generic drugs. CMS names the drug for 3,954 of them, across 42 drugs with 11 or more claims each, at $3,684,138 in total drug cost. In 2023, CMS named 3,343 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Wilner for performance year 2024, reported as part of a group. Dr. Wilner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wilner as offering telehealth. CMS counts 17 procedures of prostate resection by Dr. Wilner, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Wilner.

Dmand AI links Dr. Wilner to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 123 general payments to Dr. Wilner from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 39% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,201.

Dmand AI lists 5 awards for Dr. Wilner, most recently Regional Top Doctor in 2014.

Dr. Wilner graduated from New York University School of Medicine in 1984. Dr. Wilner is a member of ACS.

Dr. Wilner is in network with 19 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.